A Randomized, Controlled Multicenter Trial of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2014
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Ifosfamide; Methotrexate; Pirarubicin
- Indications Osteosarcoma
- Focus Therapeutic Use
- Sponsors Shandong Simcere Medgenn Bio-Pharmaceutical
- 02 Sep 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
- 06 Nov 2009 New trial record